previous compound ID: 460 next compound
InChIKey: DJDFFEBSKJCGHC-UHFFFAOYSA-N
SMILES: C1CN=C(N1)CC2=CC=CC3=CC=CC=C32.Cl

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"D Rotin" "DY Thomas" "J Goepp" "J Liao" "B Kus" "GW Carlile" "R Robert" "JW Hanrahan" "SD Macknight" "E Matthes"

chemical graph of compound 460





CID is 11079
synonyms found at PubChem are:
NAPHAZOLINE HYDROCHLORIDE, 550-99-2, Albalon, NAPHAZOLINE HCL, Rhinantin, Rhinoperd, Stricylon, Naphcon, Niazol, Rinofug, Vasocon, Opcon, Albalon Liquifilm, Clera hydrochloride, Naphazoline chloride, Privine hydrochloride, Prizole hydrochloride, Vasoclear, Coldan, Naphcon forte, Comfort Eye Drops, Degest-2, Naphazoliniumchlorid, Sanorin, Naphazolini chloridum, 2-(1-Naphthylmethyl)-2-imidazoline hydrochloride, Naphthasolium chloride, 2-(1-Naphthylmethyl)imidazoline hydrochloride, Clear Eyes, NAFAZAIR, Naphazoline (hydrochloride), UNII-MZ1131787D, HSDB 2174, Naphthylmethylimidazolinhydrochlorid, EINECS 208-989-2, NSC 35711, MLS000028434, CHEBI:7470, 2-IMIDAZOLINE HYDROCHLORIDE, Naphazoline hydrochloride (Naphcon), 2-(1-Naphthylmethyl)-2-imidazoline monohydrochloride, MZ1131787D, 2-Imidazoline, 2-(1-naphthylmethyl)-, monohydrochloride, SMR000058292, 1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-, monohydrochloride, 2-(1-Naphthylmethyl)-2-Imidazoline Hydro- Chloride, W-105587, AC1LCWB1, 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole hydrochloride, CHEMBL1706, MolPort-000-703-064, 2-(naphthylmethyl)-2-imidazoline, chloride, Albacon, Naphcon;Albalon, 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole;hydrochloride, SR-01000000067, Naphazoline hydrochloride [JAN], Prestwick_507, Albalon (TN), Vasocon (TN), component of Nasocon, Naphazoline hydrochloride [USP:JAN], Opera_ID_230, AC1L1WKK, SureCN1649580, SCHEMBL24153, C14H14N2.HCl, MLS001148448, MLS002222217, Naphazoline Hydrochloride,(S), SPECTRUM1500424, 835-31-4 (Parent), 2-Imidazoline, monohydrochloride, CTK5J7411, AOB5340, DJDFFEBSKJCGHC-UHFFFAOYSA-N, MolPort-002-904-680, HMS1568I13, HMS1920P11, Pharmakon1600-01500424, HY-B0446, NSC35711, BG0263, CCG-40122, MFCD00012554, NSC-35711, NSC757110, s2519, SBB017549, AKOS015908797, Naphazoline hydrochloride (JP17/USP), Naphazoline hydrochloride BP98 USP24, CS-2555, NC00523, NSC-757110, NCGC00094732-01, NCGC00094732-02, NCGC00094732-03, NCGC00094732-04, AN-15699, AS-16861, CPD000058292, LS-79667, SAM002554916, SC-46390, 2-(naphthalen-1-ylmethyl)-4,5-dihydro-, AB2000621, LS-175633, TR-019439, WLN: L66J B1- BT5M CN BUTJ &GH, FT-0603466, LT00114215, LT00233108, N0542, ST50319852, C07898, D00743, C-15060, I14-3428, SR-01000000067-3, 2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole hydrochloride, 4,5-Dihydro-2-(1-naphthylmethyl)-1H-imidazole Hydrochloride, 1H-Imidazole,5-dihydro-2-(1-naphthalenylmethyl)-, monohydrochloride, Naphazoline hydrochloride, European Pharmacopoeia (EP) Reference Standard, Naphazoline hydrochloride, United States Pharmacopeia (USP) Reference Standard, 35412-62-5, AKOS026749898, hydron; 2-(naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole; chloride, MCULE-8346078401